BriaCell Therapeutics Corp Warrant 2021-26.02.26 on BriaCell Therapeutics
No trades
−77.1765 USD
−26.49 M USD
0.00 USD
1.86 M
About BriaCell Therapeutics Corp
Sector
Industry
CEO
William V. Williams
Website
Headquarters
West Vancouver
Founded
2006
ISIN
CA10778Y1126
FIGI
BBG00ZF3B328
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.